ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

Group trials need prioritization, review, NCI official says.

July 25, 2003

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

Alternative to Animal Use In Research Outlined By OTA

February 21, 1986

Conversation With The Cancer Letter: Ronald DePinho Says Moon Shots Will Go On

January 18, 2013